Column Capital Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Column Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$127.18 - $173.91 $381 - $521	-3 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$159.56 - $209.29 $478 - $627	3 New	3 $1,000
Q2 2021 Aug 05, 2021	SELL	$128.63 - $176.89 $12,863 - $17,689	-100 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$93.12 - $133.99 $4,004 - $5,761	-43 Reduced 30.07%	100 $11,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $10,654 - $17,764	143 New	143 $16,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.